Evolvere Biosciences raises €450K Seed round
22 September 2024· Tonbridge, United Kingdom· health, biotech, drug_discovery, ai, synthetic_biology, b2b, software_hardware
To develop next-generation antibiotics that outcompete bacterial evolution and precisely target pathogenic bacteria.
Investors
LeadY Combinator
About Evolvere Biosciences
Stage
Seed
Headquarters
Tonbridge, United Kingdom
Founded
2021
Team Size
6–20
Sectors
healthbiotechdrug_discoveryaisynthetic_biologyb2bsoftware_hardware